56
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Increased serum hyaluronic acid in amyotrophic lateral sclerosis: Relation to its skin content

, , , , , , & show all
Pages 213-218 | Published online: 10 Jul 2009

  • Laurent UBC, Laurent TC. On the origin of hyaluronate in blood. Biochem Int 1981; 2: 195-199.
  • Fraser JRE, Laurent TC, Pertoft H, Baxter E. Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit Biochem J 1981; 200: 415-424.
  • Fraser JRE, Appelgren LE, Laurent TC. Tissue uptake of circulating hyaluronic acid. A whole body autoradiographic study. Cell Tissue Res 1983; 233: 285-293.
  • Ono S, Nagao K, Yamauchi M. Amorphous material of skin in amyotrophic lateral sclerosis: a morphologic and biochemical study. Neurology 1994; 44: 537-540.
  • Ono S, Imai T, Yamauchi M, Nagao K. Hyaluronic acid is increased in the skin and urine in patients with amyotrophic lateral sclerosis. J Neural 1996; 243: 693-699.
  • Ono S, Imai T, Aso A, Yamano T, Shimizu N, Nagao K Alterations of skin glycosaminoglycans in patients with amyotrophic lateral sclerosis. Neurology 1998; 51: 399-404.
  • Carosao JT, Cohen JA, Zawodniak J, et al. A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis. Neurology 1986; 36: 141-145.
  • Pattes BM, Harati Y, Acosta L, Jung SS, Felmus MT. Free amino acid levels in amyotrophic lateral sclerosis. Ann Neurol 1978; 3: 305-309.
  • Akimoto S, Hayashi H, Ishikawa H. Disaccharide analysis of the skin glycosaminoglycans in systemic sclerosis. Br J Dermatol 1992; 126: 29-34.
  • Fluharty AL, Click JA, Matusewicz NM, Kihara H. High-performance liquid chromatography determination of unsaturated disaccharides produced from sulfates by chondroitinases. Biochem Med 1982; 27: 352-360.
  • Kodama C, Ototani N, Isemura M, Yoshizawa Z. High-performance liquid chromatography of pyridylamino derivatives of unsaturated disaccharides produced from chondroitin sulfate isomers by chondroitinases. J Biochem 1984; 96: 1283-1287.
  • Laurent UBG, Tengblad A. Determination of hyaluronate in biological samples by a specific radioassay technique. Anal Biochem 1980; 109: 386-394.
  • Lundin Å, Engström-Laurent A, Hällgren R, Michaëlsson C. Circulating hyaluronate in psoriasis. Br J Dermatol 1985; 112: 663-671.
  • Engström-Laurent A, Feltelius N, Hällgren R, Wasteson Ä. Raised serum hyaluronate levels in sderodeima: an effect of growth factor induced activation of connective tissue cells? Ann Rheum Dis 1985; 44: 614-620.
  • Engström-Laurent A, Laurent UBG, Lilja K, Laurent TC. Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest 1985; 45: 497-504.
  • Tengblad A. Affinity chromatography on immobilized hyaluronate and its application to the isolation of hyaluronate binding proteins from cartilage. Biochim Biophys Acta 1979; 578: 281-289.
  • Fraser JRE, Laurent TC, Engström-Laurent A, Laurent UBG. Elimination of acid from the blood stream in the human. Clin Exp Pharmacol Physiol 1984; 11: 17-25.
  • Willen MD, Sorrel JM, Lekan CC, Davis BR, Caolan AI. Patterns of glycosaminoglyGin/proteoglycan immunostaining in human skin during aging. J Invest Dermatol 1991; 96: 968-974.
  • Bernstein EF, Undelhill CB, Hahn PJ, Brown DB, Uitto J. Chronic sun exposure alters both the content and distribution of dermal glycosaminoglycans. Br J Dermatol 1996; 135: 255-262.
  • Uitto J, Ohlenschlager K, Lorenzen IB. Solubility of skin collagen in normal human subjects and in patients with generalized sderoderma. Clin Chim Acta 1971; 31: 13-18.
  • Juhlin L, Tengblad A, Ortonne JP, Lacour JPH. Hyaluronate in suction blisters from patients with sderoderma and various skin disorders. Acta Derm Venereol (Stockh) 1986; 66: 409-413.
  • Ono S, Toyokura Y, Mannen T, Ishibashi Y. 'Delayed return phenomenon' in amyotrophic lateral sderosis. Acta Neurol Scand 1988; 77: 102-107.
  • Engström-Laurent A, Loff L, Nyberg A, Schröder T. Increased serum level of hyaluronate in liver disease. Hepatology 1985; 5: 638-642.
  • Frebourg T, Delpech B, Bercoff E, et al. Serum hyaluronate in liver diseases: study by enzymoimmunological assay. Hepatology 1986; 6: 392-395.
  • Levesque H, Delpech B, Le Loet X, Deshayes P. Serum hyaluronate in rheumatoid arthritis: study by affino-immunoenzymatic assay. Br J Rheumatol 1988; 27: 445-449.
  • Dahl IMS, Laurent TC. Concentration of hyaluronan in the serum of untreated cancer patients with special reference to patients with mesothelioma. Cancer 1988; 62: 326-330.
  • Deutsch HF. Some properties of human serum hyaluronic add. J Biol Chem 1957; 224: 767-774.
  • Wu AHB, Parker OS, Ford L Hyperviscosity caused by hyaluronic add in serum in a case of Wilms' tumor. Gin Chem 1984; 30: 914-916.
  • Engström-Laurent A, Hällgren R. Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 1985; 44: 83-88.
  • Hällgren R, Engström-Laurent A, Nisbeth U. Circulating hyaluronate. A potential marker of altered metabolism of the connective tissue in uremia. Nephron 1987; 46: 150-154.
  • Laurent TC, Dahl IMS, Dahl LB et al. The catabolic fate of hyaluronic add. Conned Tissue Res 1986; 15: 33-41.
  • Fraser JR, Engström-Laurent A, Nyberg A, Laurent TC. Removal of hyaluronic add from the circulation in rheumatoid disease and primary biliary cirrhosis. J Lab Gin Med 1986; 107: 79-85.
  • Liu HM. Collagens in the nervous tissue. In: Nimni ME, ed. Collagen, vol 1. Boca Raton, FL CRC Press, 1988: 243-256.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.